期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

住院老年心力衰竭患者的临床特点及预后 被引量：6

原文传递
导出
摘要 心力衰竭是老年人住院的常见原因，年龄是心力衰竭预后的主要预测指标。明确老年心力衰竭患者的临床特点及治疗中的特殊性是非常重要的。为此，我们比较老年心力衰竭患者与非老年患者临床特点和预后的差异。
作者 韩智红 吴学思 康俊萍 杜昕 张维东 陈方
机构地区 首都医科大学附属北京安贞医院心内科
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2006年第9期673-674,共2页 Chinese Journal of Geriatrics
关键词 心力衰竭患者 住院老年 临床特点 预后 预测指标 老年患者 老年人
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献8

  • 1Willem JR, Karl S. Guidelines for the diagnosis and treatment of chronic heart failure. Task Force for the Diagnosis and Treatment of Chronic Heart Failure,European Society of Cardiology. Eur Heart J, 2001,22 :1527 -1560.
  • 2Redfield MM, Karon BL, Jacobsen SJ, et al. Effect of age on vascular function, LV structure and systolic and diastolic ventrieular function in adult population. J Card Fail, 2004, S34.
  • 3Chae CU, Alnert CM, Glynn RJ, et al. Mild renal insufficiency and risk of congestive heart failure in menand women>70 years of age. AmJ Cardiol,2003, 92:682-686.
  • 4Cioffi G, Stefenelli C, Tarantini L, et al. Prevalence,predictors, and prognositic implications of improvement in left ventricular systolic function and clinical status inpatient > 70 years of age with recently diagnosed systolic heart failure. Am J Cardiol, 2003,92 : 166-172.
  • 5Goodlin SJ. Heart failure in the elderly. Expert Rev Cardiovasc Ther, 2005, 3 : 99-106.
  • 6Cioffi G, Stefenelli C. Tolerability and clinical effects of carvedilol in patients over 70 years of age with chronic heart failure due to left ventricular dysfunction. Ital Heart J Suppl, 2001,2:1319 -1329.
  • 7Masoudi FA, Rathore SS, Wang Y, et al. National patterns of use and effectiveness of angiotensin converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation,2004,110:724- 731.
  • 8诸骏仁,朱文玲,吴士尧,陈君柱,单江,蔡迺绳,吴学思,宋建平,李新立.卡维地洛治疗老年心力衰竭患者的耐受性研究[J].中华老年医学杂志,2005,24(7):489-491. 被引量：9

二级参考文献11

  • 1Packer M,Bristow MR,Cohn JN, et al. The effect of carvedilol on mortality in patients with chronic heart failure. N Engl J Med. 1996, 334:1349-1355.
  • 2Frishman WH. Carvedilol. N Engl J Med,1998, 339:1759-1765.
  • 3Weber K, Bohmeke T, Does R, et al. Hemodynamic differences between metoprolol and carvedilol in hypertensive patients. Am J Hypertens, 1998,11:614-617.
  • 4Hauf-Zacharion U, Blackwood RA, Gunawardena KA,et al. Carvedilol versus verapamil in chronic stable angina :a multicenter trial. Eur J Clin Pharmacol,1997, 52:92-100.
  • 5Dargie HJ. For the CAPRICORN investigators, effects of carvedilol on outcome of myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomised trial. Lancet, 2001, 357:1385-1390.
  • 6Lysko PG, Webh CL, Gu JJ, et al. A comparison of carvedilol and metoprolol antioxidant activities in vitro.J Cardiovasc Pharmacol,2000, 36: 277-281.
  • 7Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344:1651-1658.
  • 8Palazzuoli A, Bruni F, Puccetti L, et al. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure. Eur J Heart Fail, 2002, 4 : 765-770.
  • 9Pool-wilson P,Swedberg K,Cleland, et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the carvedilol or metoprolol European trial ( COMET ): randomized controlled trial. Lancet, 2003,362 : 7-13.
  • 10慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量：2414

共引文献8

同被引文献60

引证文献6

二级引证文献35

中华老年医学杂志
2006年 第9期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部